Loma Linda to Host Rare Kidney Disease Conference | Docwire News
Faculty physicians and surgeons of the Division of Nephrology at Loma Linda University School of Medicine will host the Rare Kidney Disease Conference December 7-8, 2024.
Related Articles
Lessons to be learned as Celta Vigo unsettle Barcelona and steal precious points
The Blaugrana aren’t able to weather the chaos in Galicia
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH treatment
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by Ansaar…
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH treatment
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by Ansaar…
Cardiovascular Disease Affects Patients With CKD Up to 28 Years Earlier
Adults with chronic kidney disease (CKD) or type 2 diabetes develop cardiovascular diseases (CVD) at younger ages.
Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric
Kidneys are vital for vitamin D metabolism and disruptions in both production and catabolism occur in chronic kidney disease. Although vitamin D activation occurs in…
In Search of a Second Opinion
When patients turn to professional societies like the AMA or the American College of Physicians or the American Association of Pediatrics for vital health information,…
Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Compared with conventional guide catheters, the use of balloon guide catheters led to worse functional recovery in patients receiving endovascular thrombectomy for intracranial large vessel…
Bevacizumab: The future of chronic subdural hematoma – Yash Verma, Mariam Abdelghaffar, Onam Verma, Aryan Gajjar, Sherief Ghozy, David F Kallmes, 2024
Bevacizumab (BCZ), commercially known as Avastin, is a monoclonal antibody that targets vascular endothelial growth factor (VEGF). Initially recognized as a bre…
Aquaporin-1 and Osmosis: From Physiology to Precision in… : Journal of the American Society of Nephrology
ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across…
